Necrotising myositis, also known as immune-mediated necrotizing myopathy, is a rare muscle disease that causes severe weakness on both sides of the body by triggering the death of muscle cells. This autoimmune condition typically affects muscles closest to the body’s center, such as the shoulders, hips, and thighs, making everyday activities like climbing stairs or lifting arms overhead increasingly difficult.

Understanding the Disease

Necrotising myositis is an autoimmune disorder, which means the body’s immune system mistakenly attacks healthy tissue instead of protecting it. In this case, the immune system targets muscle fibers, causing them to break down and die in a process called necrosis. This muscle cell death leads to progressive weakness that can develop over days, weeks, or months.^[1]

This disease is distinct from other muscle conditions because under the microscope, doctors find muscle cells that have died rather than the typical signs of inflammation seen in similar diseases. Before researchers recognized it as a separate condition, many patients were incorrectly diagnosed with polymyositis because the symptoms looked similar. However, specific blood tests that detect certain autoantibodies and muscle tissue examination now help doctors tell these conditions apart.^[2]

The disease primarily affects the proximal muscles, meaning those muscles that sit closest to the center of your body. These include the shoulders, upper arms, hips, thighs, neck, and back muscles. Because these muscles are essential for so many daily movements, their weakness creates significant challenges in everyday life.^[3]

Epidemiology

Necrotising myositis is considered a very rare disease. Among all types of inflammatory muscle diseases, which collectively affect between 1.16 and 19 people per million each year, necrotising myopathy represents approximately 10 percent of cases.^[5] Despite its rarity, the detection rate is increasing as doctors become more aware of the condition and better testing methods become available.

The disease typically strikes adults between the ages of 40 and 60 years, though it can affect people outside this age range. Both men and women can develop necrotising myositis, though the patterns differ depending on which specific type they have. The onset is usually relatively quick compared to other muscle diseases, developing over a period of days, weeks, or a few months rather than years.^[1]

Research suggests that younger patients who develop this condition may experience more severe disease. Both children and young adults with necrotising myositis can present with features that look like muscular dystrophy, though these features may potentially be reversible with proper treatment. This makes early diagnosis and aggressive therapy particularly important in younger patients.^[2]

Causes

The exact cause of necrotising myositis remains poorly understood, but researchers have identified several triggers that can prompt the body to attack its own muscle tissue. These triggers appear to stimulate an autoimmune response where the immune system begins targeting muscle cells for destruction.^[5]

One well-documented trigger is statin medication, a group of drugs commonly prescribed to control cholesterol levels in the blood. Some people who take statins, or even consume dietary sources that contain similar compounds like red yeast rice and oyster mushrooms, may develop specific autoantibodies that lead to necrotising myositis. However, it’s important to note that sometimes no environmental triggers can be found to explain why someone develops the disease.^[1]

Other potential triggers include certain types of cancer, which have been associated with the development of necrotising myopathy. Some patients develop the condition in connection with other connective tissue diseases, which affect the tissue that holds together different parts of the body. Since muscles are composed largely of connective tissue, this association makes biological sense.^[5]

In some cases, viral infections like HIV may trigger the disease. The HIV virus significantly weakens the immune system’s normal responses, and in some patients, this altered immune function causes the body to attack its own muscle cells instead of fighting only foreign invaders.^[5]

Risk Factors

Several factors may increase a person’s likelihood of developing necrotising myositis, though having these risk factors does not mean someone will definitely develop the disease. Understanding these factors helps doctors identify who might benefit from closer monitoring.

Age plays a significant role, with adults in the 40 to 60 age range being at highest risk. However, the disease can strike at any age, including children, who may show different patterns of symptoms that can sometimes mimic inherited muscle diseases.^[1]

Prior exposure to statin medications represents another risk factor, particularly for developing the subtype associated with anti-HMGCR autoantibodies. This connection highlights why doctors ask detailed questions about medication history when evaluating patients with muscle weakness. Similarly, consumption of dietary sources containing HMGCR inhibitors, though much less common than prescription statins, may also pose a risk.^[1]

People with existing autoimmune conditions or connective tissue diseases may face increased risk. The body’s tendency to mount immune responses against its own tissues in one area can sometimes extend to other tissues, including muscles. Additionally, certain types of cancer have been weakly linked to necrotising myositis, though this connection is not yet fully understood.^[8]

The presence of specific autoantibodies in the blood indicates not just risk but active disease. These include anti-SRP (signal recognition particle) and anti-HMGCR autoantibodies, which help doctors classify the disease into different subtypes with distinct characteristics and potentially different treatment approaches.^[2]

Symptoms

The hallmark symptom of necrotising myositis is progressive muscle weakness that affects both sides of the body equally. This symmetrical weakness means if your right shoulder is weak, your left shoulder will be similarly affected. The weakness typically develops in proximal muscles first, creating a characteristic pattern of difficulties.^[1]

People with necrotising myositis often notice they have trouble climbing stairs or standing up from a seated position, especially from low chairs. The weakness in hip and thigh muscles makes these movements increasingly challenging. Similarly, lifting objects overhead becomes difficult as shoulder and upper arm muscles weaken. Simple tasks like washing hair, brushing hair, or reaching items on high shelves can become frustratingly difficult or impossible.^[3]

Falls become more common, and more worryingly, people may find they cannot get back up after falling. The leg muscles lack the strength to push the body upright, and the arm muscles cannot provide enough support to pull up. This creates significant safety concerns and often leads to loss of independence.^[1]

Beyond the proximal muscles, other muscle groups can sometimes be affected, though this is less common. The neck muscles may weaken, making it hard to hold the head up or move it normally. When throat muscles are involved, swallowing becomes difficult, a condition called dysphagia. This can lead to choking episodes or cause food and liquids to enter the airways instead of the esophagus.^[5]

Breathing difficulties may occur if the chest muscles and diaphragm become weak. Some patients experience shortness of breath or develop a chronic dry cough. In the most severe cases, the respiratory muscles may become so weak that breathing support becomes necessary.^[1]

Many patients report an overwhelming sense of fatigue and tiredness that goes beyond normal exhaustion. This fatigue can be debilitating and affects quality of life significantly. Unlike other forms of myositis, necrotising myositis typically does not cause skin rashes or affect other organs like the joints or lungs, though patients with anti-SRP antibodies may occasionally experience inflammation in the lungs and heart.^[1][3]

The severity of symptoms can vary considerably between patients. Some experience relatively mild weakness that progresses slowly, while others develop severe, rapidly progressing weakness that can render them bedbound and dependent on others for daily activities. This variability makes each patient’s experience unique.^[8]

Prevention

Because the exact causes of necrotising myositis are not fully understood and the disease involves an autoimmune response, there are no proven strategies to prevent its development. The condition is not contagious and cannot be passed from person to person like an infection.

For people taking statin medications, it’s essential to understand that these drugs should not be stopped out of fear of developing necrotising myositis. Statins save many lives by preventing heart attacks and strokes, and the vast majority of people taking them experience no serious problems. The risk of developing necrotising myositis from statins is extremely small compared to the proven benefits these medications provide for heart health.^[8]

People who notice unusual muscle weakness, particularly if it affects both sides of the body and involves difficulty with activities like climbing stairs or lifting arms overhead, should seek medical evaluation promptly. While early detection does not prevent the disease, it does allow for earlier treatment, which may help prevent long-term disability and muscle damage.^[2]

For those already diagnosed with necrotising myositis, preventing disease flares and complications becomes the focus. This involves adhering to prescribed treatment regimens, attending regular follow-up appointments, and promptly reporting any changes in symptoms. Patients may experience flare-ups triggered by illness, stress, poor dietary practices, or extreme weather, so managing these factors where possible may help maintain stability.^[14]

Pathophysiology

In necrotising myositis, the fundamental problem lies in how the body’s immune system interacts with muscle tissue. Unlike healthy immune responses that protect against infections and foreign invaders, the immune system in these patients mistakenly identifies muscle cells as threats and attacks them.^[3]

The hallmark pathological feature is muscle fiber necrosis, meaning muscle cells die and break down. When doctors examine muscle tissue under a microscope through a muscle biopsy, they see dead and dying muscle cells rather than the inflammatory cell invasion typical of other muscle diseases. While some inflammatory cells may be present, they are not the dominant finding. This pattern of predominant necrosis with minimal inflammation distinguishes necrotising myositis from conditions like polymyositis.^[1]

The disease process involves specific autoantibodies circulating in the blood. These are immune proteins that target the body’s own tissues. In necrotising myositis, two main types have been identified: anti-SRP and anti-HMGCR antibodies. These autoantibodies recognize specific proteins within muscle cells and appear to play a direct role in muscle fiber damage and death.^[2]

When muscle cells die, they release an enzyme called creatine kinase into the bloodstream. This enzyme is normally contained inside healthy muscle cells, so its presence in blood indicates muscle damage. Patients with necrotising myositis typically have highly elevated creatine kinase levels, often much higher than in other muscle diseases. These levels can reach thousands of units per liter, whereas normal levels are usually below a few hundred.^[2]

The muscle damage is not limited to just cell death. Over time, damaged muscles undergo changes that make recovery more difficult. Muscle tissue may be replaced by fat and fibrous scar tissue, a process that can begin early in the disease course. This replacement is often irreversible, which explains why prompt and aggressive treatment is so critical. The longer muscle cells remain under attack without effective treatment, the more likely permanent damage becomes.^[2]

The biochemical and mechanical changes in affected muscles interfere with normal muscle contraction. Muscles rely on intricate cellular machinery to convert chemical energy into mechanical force for movement. When muscle cells die and are replaced by non-functional tissue, this machinery is destroyed. The remaining healthy muscle fibers must work harder to compensate, but eventually, there are too few functional fibers left to generate adequate force, resulting in weakness.^[3]

Different subtypes of necrotising myositis show distinct pathophysiological features. Patients with anti-SRP antibodies tend to have more severe muscle involvement and may develop complications affecting the heart and lungs. Those with anti-HMGCR antibodies often have a history of statin exposure, though not always, and may respond differently to treatment. A third group lacks these specific antibodies but still shows the characteristic pattern of muscle necrosis; these patients are called seronegative.^[1]